Why is "Congenital adrenal hyperplasia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-16 21:45:44
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Congenital_adrenal_hyperplasia entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-16 and was most recently seen on 2026-03-16.
Wikipedia Overview
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders characterized by impaired cortisol synthesis. It results from the deficiency of one of the five enzymes required for the synthesis of cortisol in the adrenal cortex. Most of these disorders involve excessive or deficient production of hormones such as glucocorticoids, mineralocorticoids, or sex steroids, and can alter development of primary or secondary sex characteristics in some affected infants, children, or adults. It is one of the most common autosomal recessive disorders in humans.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Reduced cortical thickness in individuals with congenital adrenal hyperplasia (CAH) - Nature
-
Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia - Frontiers
-
Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia - PR Newswire
-
Imaging Spectrum and Surveillance of Testicular Adrenal Rest Tumours in Congenital Adrenal Hyperplasia: A Case Series - Cureus
-
The Future of Congenital Adrenal Hyperplasia (CAH) Treatment: New and Emerging Therapies and Technologies - Everyday Health
-
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia - PR Newswire
-
Editorial: Advanced genomic techniques for congenital adrenal hyperplasia - Frontiers
-
A Delayed Presentation of Salt-Wasting Congenital Adrenal Hyperplasia Due to 3β-Hydroxysteroid Dehydrogenase Deficiency in an Infant: A Case Report - Cureus
-
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026 - PR Newswire
-
Post-ACTH peak cortisol response is associated with genotype in children with nonclassic congenital adrenal hyperplasia - Frontiers
-
Atypical Presentation of Acute Appendicitis in a Young Adult With Congenital Adrenal Hyperplasia on Chronic Glucocorticoid Therapy - Cureus
-
Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026 - PR Newswire
-
Bone health in adolescents with congenital adrenal hyperplasia: exploring the interplay between glucocorticoid therapy, hormonal imbalance and puberty - Frontiers
-
Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia - PR Newswire
-
Unveiling Salt-Wasting Congenital Adrenal Hyperplasia in an Infant: A Diagnostic Challenge - Cureus
-
Case Report: Challenges of an extremely delayed diagnosis of classic congenital adrenal hyperplasia in a completely virilized 46,XX patient - Frontiers
-
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients with Classic Congenital Adrenal Hy - PR Newswire
-
A Neonatal Salt-Wasting Crisis Mimicking Congenital Adrenal Hyperplasia: A Case of Transient Pseudohypoaldosteronism - Cureus
-
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026 - PR Newswire
-
Crinecerfont confers long-term benefits for children with congenital adrenal hyperplasia - Healio
-
Two Distinct Endocrine Conditions in a Single Pediatric Patient: Congenital Adrenal Hyperplasia and Type 1 Diabetes Mellitus - Cureus
-
The Path to Pregnancy: Navigating Fertility With Congenital Adrenal Hyperplasia (CAH) - Everyday Health
-
Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia - Frontiers
-
Giant adrenal tumor as a manifestation of congenital adrenal hyperplasia - mp.pl
-
Nerve Sparing Clitoroplasty via a Ventral Approach in a Child With Congenital Adrenal Hyperplasia: A Case Report and Review of the Surgical Technique - Cureus
-
Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026 - PR Newswire
-
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: clinical, biochemical and molecular characteristics and long-term outcomes - Anales de Pediatría
-
Leydig cell tumor mimicking congenital adrenal... : IJEM Case Reports - Ovid
-
Crinecerfont shows durable hormone control, lower steroid doses in pediatric CAH at 2 years - Contemporary Pediatrics
-
Perception of women with classic congenital adrenal hyperplasia and their parents on genital surgery and a diagnosis of differences of sex development: a retrospective survey - springermedizin.de
-
Classic Congenital Adrenal Hyperplasia Treatment Hard on the Bones - MedPage Today
-
Addressing CAH Through Comprehensive Care and Research - NewYork-Presbyterian
-
Congenital Adrenal Hyperplasia - The New England Journal of Medicine
-
Genetic diagnosis of CYP21A2-related CAH: adaptive sampling long-read sequencing is an accurate and scalable solution | European Journal of Human Genetics - Nature
-
Atumelnant for Congenital Adrenal Hyperplasia Agent Granted FDA Orphan Drug Designation - Patient Care Online
-
FDA Grants Atumelnant Orphan Drug Designation for Congenital Adrenal Hyperplasia - HCPLive
-
Long‐term health consequences of congenital adrenal hyperplasia - Pofi - 2024 - Clinical Endocrinology - Wiley Online Library
-
Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency - The New England Journal of Medicine
-
Testicular adrenal rest tumor without congenital... : International Journal of Urology - Ovid
-
How to Manage Mental Health and Congenital Adrenal Hyperplasia - Everyday Health
-
Crinetics Advances Potential Neurocrine Competitor With Fresh Data and Money - BioSpace
-
The corpus callosum in people with congenital adrenal hyperplasia (CAH) - Nature
-
Infertility risk assessment with ultrasound in congenital adrenal hyperplasia male patients - Nature
-
Congenital Adrenal Hyperplasia - Endocrine Society
-
Congenital adrenal hyperplasia causing hypertension: an illustrative review - Nature
-
Biomarkers in congenital adrenal hyperplasia - Bacila - 2024 - Clinical Endocrinology - Wiley Online Library
-
What Happens if CAH Isn’t Treated? - Cleveland Clinic Health Essentials
-
Congenital Adrenal Hyperplasia Management Across the Lifespan - Patient Care Online
-
Congenital Adrenal Hyperplasia: Evelyn’s Story - Children's Hospital of Philadelphia
-
Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications - Endocrine Society
-
What Hormones Are Affected by CAH? - Cleveland Clinic Health Essentials
-
Coexistence of Bilateral Giant Adrenal Myelolipomas and Congenital Adrenal Hyperplasia: A Case Report - Cureus
-
Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026 - Finansavisen
-
Height, weight growth patterns differ for children with CAH vs. general population - Healio
-
Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden - Frontiers
-
‘Game Changer’ Approved for Congenital Adrenal Hyperplasia - Medscape
-
Classic congenital adrenal hyperplasia - Tidsskrift for Den norske legeforening
-
Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia - Frontiers
-
Free Cortisol and Free 21-Deoxycortisol in the Clinical Evaluation of Congenital Adrenal Hyperplasia - Endocrine Society
-
New horizons in treatments for classic congenital adrenal hyperplasia (CAH) - Mayo Clinic Press
-
Congenital Adrenal Hyperplasia: Charlotte and Michael’s Story - Children's Hospital of Philadelphia
-
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency - Nature
-
BridgeBio Pharma Drops Development of Congenital Adrenal Hyperplasia Gene Therapy BBP-631 - CGTLive®
-
Neurocrine Biosciences drug for congenital adrenal hyperplasia succeeds in late-stage trial - statnews.com
-
Computer Vision Predicts Congenital Adrenal Hyperplasia - USC Viterbi School of Engineering
-
FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia in Adults and Children in Landmark Decision - Patient Care Online
-
Rare forms of congenital adrenal hyperplasia - Gurpinar Tosun - 2024 - Clinical Endocrinology - Wiley Online Library
-
Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia - PR Newswire
-
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia - Nowotny - 2024 - Clinical Endocrinology - Wiley Online Library
-
Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy - Wiley & Sons
-
After decades with only one option, new therapies emerge for congenital adrenal hyperplasia - Healio
-
Editorial: Management of Females with Congenital Adrenal Hyperplasia - Frontiers
-
VisualAbstract: Crinecerfont Improves Outcomes in Pediatric Congenital Adrenal Hyperplasia Patients - 2 Minute Medicine
-
A Primer on Congenital Adrenal Hyperplasia with Expert Steroid Biologist Richard Auchus, MD, PhD - Patient Care Online
-
Classic congenital Adrenal Hyperplasia Diagnosed in the Newborn Period - Children's Hospital of Philadelphia
-
Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report - Cureus
-
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community - PR Newswire
-
FDA Approves Crinecerfont for Adult, Pediatric Patients with Congenital Adrenal Hyperplasia - Pharmacy Times
-
CAHtalyst Trial Shows Crenessity Sustains Efficacy in Classic Congenital Adrenal Hyperplasia - appliedclinicaltrialsonline.com
-
Testicular Adrenal Rest Tumors in a Patient With Congenital Adrenal Hyperplasia - Cureus
-
Apparent Clitoromegaly in a Newborn: A Case of Congenital Adrenal Hyperplasia - Cureus
-
Navigating Cervical Cancer Risk in a Patient With Classic Congenital Adrenal Hyperplasia (CAH): A Case Report - Cureus
-
Classic vs Nonclassic CAH: Types Explained - Mayo Clinic Press
-
Reproductive Function and Fertility in Women with Congenital Adrenal Hyperplasia - EMJ
-
Bone Age and Growth Prediction in Congenital Adrenal Hyperplasia - Endocrinology Advisor
-
Classic Congenital Adrenal Hyperplasia: Understanding Treatment Options - MedPage Today
-
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: clinical, biochemical and molecular characteristics and long-term outcomes - Anales de Pediatría
-
Study shows crinecerfont aids patients with congenital adrenal hyperplasia - Medical Xpress
-
FDA, EMA Grant Lu AG13909 Orphan Drug Status for Treatment of Congenital Adrenal Hyperplasia - Patient Care Online
-
Crinecerfont safe, effective in treating children with congenital adrenal hyperplasia - Contemporary Pediatrics
-
Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency - Nature
-
Neurocrine Biosciences Presents New Analysis of CAHtalog® Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure, Suboptimal Disease Control or Both at ENDO 2025 - PR Newswire
-
Prostatic tissue in 46XX congenital adrenal hyperplasia: Case report and literature review - Wiley Online Library
-
FDA Approves First Drug for Classic Congenital Adrenal Hyperplasia in 70 Years - MedPage Today
-
Establishing the Cut-Off Values of 17-Hydroxyprogesterone for Diagnosing Congenital Adrenal Hyperplasia: A Prospective Observational Study in a Tertiary Care Hospital - Cureus
-
Congenital Adrenal Hyperplasia: A Newborn With Ambiguous Genitalia - Consultant360
-
Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia - Nature
-
Congenital Adrenal Hyperplasia: Navigating a Rare, Lifelong Condition Often Diagnosed at Birth - St. Louis American
-
Abiraterone in Classic Congenital Adrenal Hyperplasia - Endocrine Society
-
Congenital adrenal hyperplasia - The Lancet
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.